FIgure 2: A summary of all the non-melanoma lesions that were referred using the proforma as suspected melanomas it is hard to quantify the effort, resources, and time required to train GPs and the success of such an undertaking. We therefore argue that all suspicious pigmented lesions referred to secondary care be triaged as urgent. q
and in communities, has led to a consistent fall in the disease detection coefficient over the years, from 75.5 in 1990 to 11.07 in 2016.³ However, it is a State that has the uniqueness of a reference center (Alfredo da Matta Foundation) being in charge of the Leprosy Control Program since its inception, with the deactivation of the isolation colony, which facilitates the execution of control activities by having a specialized and engaged team. Among these activities, the active search for cases in the communities is a priority strategy and, in recent years, has been done systematically, monthly, on a Saturday morning in the physical space of a school or health service, with the so-called dermatological care units, with a multidisciplinary team. 4, 5 Dear Editor, Worldwide the incidence of melanoma is increasing faster than of any other cancer. Early detection is critical in reducing mortality and morbidity, and therefore general practitioners (GPs) need to be able to screen effectively between benign and suspicious lesions. 1, 2 Interventions that improve the accuracy of secondary care triaging may be used to prioritize patients with malignant lesions and help combat the hindrances of long waiting times. GPs referring suspected melanomas to our department were asked to use a pro forma with an integrated 10-point Likert scoring tool and grade the likelihood of lesions being melanomas (1 least likely, 10 most likely). Based on results from a previous pilot study in our department, all patients referred with a score ≥4 were triaged to an urgent appointment and those with a score of ≤3 to a soon appointment.
Our aim was to assess the usefulness of this proforma in discriminating between malignant melanomas (MM) and other pigmented lesions (NM). We retrospectively assessed the clinical records of all (n=75) patients diagnosed with MM in 2016 who were referred using the above proforma and matched them with 75 consecutive NM patients. Two hundred patients with primary MM were diagnosed in our department in 2016, 75 (37.5%) of which with the above proforma. In the MM group 38 patients were male and 37 female, with a mean age of 59.8 years. In the NM group, 29 patients were male and 46 female, with a mean age of 48.4 years. Both groups had overlapping scores ranging from 1 -10 ( Figure 1 ). Median and mean scores in the MM group were 6 and 6.02. The NM group had a
